期刊文献+

子宫内膜癌中pRb2/p130的表达及意义

Expression of pRb2/p130 Gene in Human Endometrial Carcinoma Cells and the Significance
下载PDF
导出
摘要 目的探讨子宫内膜组织中pRb2/p130的表达及其与子宫内膜癌临床病理特征的关系。方法应用免疫组化SP法检测pRb2/p130在28例正常增生期子宫内膜、20例不典型增生子宫内膜、30例子宫内膜腺癌组织中的表达。结果pRb2/p130阳性表达率在正常增生期子宫内膜、不典型增生子宫内膜、子宫内膜腺癌组织中依次递减(分别为82.1%、55.0%、23.3%),且子宫内膜腺癌和不典型性增生中明显低于正常增生期子宫内膜,差异均有统计学意义(P<0.05);pRb2/p130阳性表达缺失与组织分化程度相关(r=-0.446,P<0.05),与临床分期、子宫肌层浸润程度无相关性(P>0.05)。结论在子宫内膜癌中pRb2/p130的表达下降或缺失是一个频发事情,其恶性度愈高阳性率愈低,提示pRb2/p130与子宫内膜癌的发生、发展密切相关,并在其发病机制中起着重要的作用。 Objective To investigate the expression of pRb2/p130 gene and its relationship with the patholgical clinical features of human endometrial carcinoma. Methods The levels of pRb2/P130 protein were examined with immunohistochemical SP method in 28 staples of normal endometrial tissue,20 samples of atypical endometrial hyperplasia and 30 samples of endometrial adenocarcinomas. Results The positive rate of pRb2/p130 protein in the normal endometrium,atypical endometrial hyperplasia cells and endometrial adenocarcinoma cells was respectively 82.1 % ,55.0% and 23.3 %. pRb2/p130 protein in endometrial atypical hyperplasia or endometrial adenocarcinoma was significantly lower than that in the normal tissue (P〈0. 05). The positive expression of pRb2/p130 gene was related to histological differentiation (r=-0.446 ,P〈0.05), but it's not related to clinical stages and depth of invasion (P〉0.05). Conclusion Descent or de- letion of the expression of pRb2/p130 gene is of a frequent incidence in human endometrial carcinoma. The positive rate of pRb2/p130 expression is reversly proportionate to malignant degree of endometrial carcinoma,which indicats that pRb2/p130 plays an important role in the development and pathogenesis of endometrial carcinoma.
作者 支霜 傅芬
出处 《江西医学院学报》 CAS 2009年第6期22-24,共3页 Acta Academiae Medicinae Jiangxi
关键词 子宫内膜癌 PRB2/P130 免疫组织化学 endometrial carcinoma pRb2/p130 immunohistochemistry
  • 相关文献

参考文献9

  • 1Hanahan D,Weinberg R A.The Hallmarks of Cancer[J].Cell,2000,100(1):57-70.
  • 2Mo L,Zheng X,Huang H Y,et al.Hyperactivation of Ha-ras Oncogene,but Not Ink4a/Arf Deficiency,Triggers Bladder Tumorigenesis[J].J Clin Invest,2007,117(2):314-325.
  • 3Mayol X,Grana X,Baldi A,et al.Cloning of a New Number of the Retinoblastoma Gene Family (pRb2) Which Binds to the E1A Transforming Domain[J].Oncogene,1993,8(9):2561-2566.
  • 4D′Andrilli G,Masciullo V,Bagella L,et al.Frequent Loss of pRb2/p130 in Human Ovarian Carcinoma[J].Clin Cancer Res,2004,10(9):3098-3103.
  • 5Claudio P P,Russo G,Kumar C A,et al.pRb2/p130,Vascular Endothelial Growth Factor,p27 (KIP1),and Proliferating Cell Nuclear Antigen Expression in Hepatocellular Carcinoma:Their Clinical Significance[J].Clin Cancer Res,2004,10(10):3509-3517.
  • 6Classon M,Dyson N.p107 and p130:Versatile Proteins with Interesting Pockets[J].Exp Cell Res,2001,264(1):135-147.
  • 7Claudio P P,Howard C M,Pacilio C,et al.Mutations in the Retinoblastoma-related Gene RB2/p130 in Lung Tumors and Suppression of Tumor Growth in Vivo by Retrovirus-mediated Gene Transfer[J].Cancer Res,2000,60(2):372-382.
  • 8胡雪君,金波,马艳菊,温华,康健,刘云鹏.Rb2/p130基因编码蛋白在非小细胞肺癌中的表达及临床意义[J].中国医科大学学报,2006,35(6):631-633. 被引量:9
  • 9Cinti C,Claudio P P,Howard C M,et al.Genetic Alterations Disrupting the Nuclear Localization of the Retinoblastoma-related Gene RB2/p130 in Human Tumor Cell Lines and Primary Tumors[J].Cancer Res,2000,60(2):383-389.

二级参考文献7

  • 1ESPOSITO V,BALDI A,De LUCA A,et al.Cell cycle related proteins as prognostic parameters in radically resected non-small cell lung cancer[J].J Clin Pathol,2005,58 (7):734-739.
  • 2RUSSO G,CLAUDIO PP,FU Y,et al.pRB2/p130 target genes in non-small lung cancer cells identified by microarray analysis[J].Oncogene,2003,22 (44):6959-6969.
  • 3CLUAIDIO PP,HOWARD CM,PACILIO C,et al.Mutations in the retinoblastoma-related gene Rb2/p130 in lung tumors and suppres sion of tumor growth in vivo by retrovirus-mediated gene transfer[J].Cancer Res,2000,60 (2):372-382.
  • 4BALDI A,ESPOSITO V,De LUCA A,et al.Differential expression of Rb2/p130 and p107 in normal human tissues and in primary lung cancer[J].Clin Cancer Res,1997,3 (10):1691-1697.
  • 5HU XJ,GENMA A,HOSOYA Y,et al.Reduced transcription of the Rb2/p130geneinhumanlungcancer[J].Mol Carcinog,2003,38 (3):124-129.
  • 6BURKE L,FLIEDER DB,GUINEE DG,et al.Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma[J].Clin Cancer Res,2005,11 (1):232-241.
  • 7ESPOSITO V,BALDI A,TONINI G,et al.Analysis of cell cycle regulator proteins in non-small cell lung cancer[J].J Clin Pathol,2004,57(1):58-63.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部